Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion.

The transition from exogenous glucose delivery to endogenous glucose production late after glucose ingestion is not solely attributable to dissipation of insulin and, therefore, must also involve factors that actively raise the plasma glucose concentration--glucose counterregulatory factors. We have shown that the secretion of two of these, glucagon and epinephrine, is specific for glucose ingestion and temporally related to the glucose counterregulatory process. To determine the physiologic roles of glucagon and epinephrine in postprandial glucose counterregulation, we produced pharmacologic interventions that resulted in endogenous glucagon deficiency with and without exogenous glucagon replacement, adrenergic blockade, and adrenergic blockade coupled with glucagon deficiency starting 225 min after the ingestion of 75 g of glucose in normal subjects. Also, we assessed the effect of endogenous epinephrine deficiency alone and in combination with glucagon deficiency late after glucose ingestion in bilaterally adrenalectomized subjects. Glucagon deficiency resulted in nadir plasma glucose concentrations that were approximately 30% lower (P less than 0.01) than control values, but did not cause hypoglycemia late after glucose ingestion. This effect was prevented by glucagon replacement. Neither adrenergic blockade nor epinephrine deficiency alone impaired the glucose counterregulatory process. However, combined glucagon and epinephrine deficiencies resulted in a progressive fall in mean plasma glucose to a hypoglycemic level late after glucose ingestion; the final glucose concentration was 40% lower (P less than 0.02) than the control (epinephrine deficient) value in these patients, and was nearly 50% lower (P less than 0.001) than the control value and approximately 30% lower (P less than 0.05) than the glucagon-deficient value in normal subjects. We conclude (a) the transition from exogenous glucose delivery to endogenous glucose production late after glucose ingestion is the result of the coordinated diminution of insulin secretion and the resumption of glucagon secretion. (b) Epinephrine does not normally play a critical role in this process, but enhanced epinephrine secretion compensates largely and prevents hypoglycemia when glucagon secretion is deficient.

[1]  J. Miller,et al.  Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects. , 1983, The Journal of clinical investigation.

[2]  H. Shamoon,et al.  Selective counterregulatory hormone responses after oral glucose in man. , 1982, The Journal of clinical endocrinology and metabolism.

[3]  A. Grubb,et al.  Interference of immunoglobulins in two glucagon radioimmunoassays. , 1982, Clinical chemistry.

[4]  R. Rizza,et al.  Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. , 1981, The Journal of clinical endocrinology and metabolism.

[5]  K. Polonsky,et al.  Hepatic Extraction of Plasma Immunoreactive Glucagon Components: Predilection for 3500-dalton Glucagon Metabolism by the Liver , 1981, Diabetes.

[6]  R. Sherwin,et al.  Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. , 1981, Journal of Clinical Endocrinology and Metabolism.

[7]  K. Polonsky,et al.  A familial glucagonoma syndrome: genetic, clinical and biochemical features. , 1981, The American journal of medicine.

[8]  P. Cryer Glucose Counterregulation in Man , 1981, Diabetes.

[9]  K. Polonsky,et al.  Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon. , 1981, The American journal of physiology.

[10]  R. Rizza,et al.  Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. , 1980, Metabolism: clinical and experimental.

[11]  R. M. Walter,et al.  Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects. , 1980, Metabolism: clinical and experimental.

[12]  P. Cryer,et al.  Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. , 1980, The Journal of clinical endocrinology and metabolism.

[13]  P. Cryer,et al.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.

[14]  R. Rizza,et al.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. , 1979, The Journal of clinical investigation.

[15]  R. Rizza,et al.  Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. , 1979, The Journal of clinical investigation.

[16]  P. Cryer,et al.  Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. , 1979, The American journal of physiology.

[17]  T. McDonald,et al.  Initial splanchnic extraction of ingested glucose in normal man. , 1978, Metabolism: clinical and experimental.

[18]  J. Jaspan,et al.  The role of the liver in glucagon metabolism. , 1977, The Journal of clinical investigation.

[19]  P. Cryer,et al.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. , 1976, The New England journal of medicine.

[20]  R. Unger,et al.  Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs. , 1975, Metabolism: clinical and experimental.

[21]  K. Tranberg,et al.  Pancreatic glucagon response to an ordinary meal. , 1975, Scandinavian journal of gastroenterology.

[22]  J. Kinney,et al.  Concentrations of Glucagon and the Insulin: Glucagon Ratio in the Portal and Peripheral Circulation 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.